Scotts Miracle-Gro Securities Investigation
Analysis based on 6 articles · First reported Aug 10, 2026 · Last updated Sep 04, 2026
The ongoing investigation and partial denial of the motion to dismiss prolong legal uncertainty for Scotts Miracle-Gro, potentially weighing on its stock and increasing litigation costs. The event may also signal continued scrutiny of the company's disclosures, affecting investor confidence.
Kahn Swick & Foti, LLC (KSF) continues its investigation into Scotts Miracle-Gro Company (SMG) regarding potential breaches of fiduciary duties by its officers and directors. The investigation stems from SMG's August 2, 2023 disclosure of disappointing fiscal third quarter results, including a 6% decline in quarterly sales, a 420 basis point decline in gross margin, a 25% cut to fiscal year EBITDA guidance, and a $20 million write-down of pandemic-driven excess inventories. Following this news, SMG's share price fell 19%, from $71.44 to $57.86. Subsequently, SMG and certain executives were sued in a securities class action lawsuit alleging failure to disclose material information in violation of federal securities laws. The court recently denied SMG's motion to dismiss in part, allowing the case to proceed. KSF's investigation focuses on whether SMG's officers and directors breached fiduciary duties or violated state or federal laws.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard